Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment

Journal of Paediatrics and Child Health

Volumn 45, Issue 12, 2009, Pages 720-726

  Ward, Anna ^a   Hayden, Suzie ^b   Dexter, Mark ^b,c   Scheinberg, Adam ^d,e  

^a Rehabilitation Department   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c Westmead Private Hospital   (Australia)

^d LIVERPOOL HOSPITAL   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Complication; Dystonia; Intrathecal baclofen; Spasticity

Indexed keywords

BACLOFEN;

ADOLESCENT; ARTICLE; CATHETER INFECTION; CATHETER OCCLUSION; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG OVERDOSE; DRUG WITHDRAWAL; DYSTONIA; EROSION; FEMALE; GOAL ATTAINMENT; HUMAN; LIQUORRHEA; MALE; MEDICAL RECORD REVIEW; MINIPUMP; MUSCLE HYPOTONIA; PATIENT POSITIONING; PATIENT TRANSPORT; PERFORMANCE MEASUREMENT SYSTEM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY ARREST; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROMA; SPASTICITY; TENSION HEADACHE; TREATMENT OUTCOME; WHIPLASH INJURY;

ADOLESCENT; BACLOFEN; CHILD; CHILD, PRESCHOOL; DYSTONIA; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MEDICAL AUDIT; MUSCLE SPASTICITY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 73449147350     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2009.01601.x     Document Type: Article

References (31)

1. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991 265 : 1418 1422.
2. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993 270 : 2475 2477.
3. Albright AL, Awaad Y, Muhonen M et al. Performance and complications associated with the synchromed 10-mL infusion pump for intrathecal baclofen administration in children. J. Neurosurg. 2004 101 : 64 8.
4. Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Dev. Med. Child Neurol. 2000 42 : 634 645.
5. Albright AL, Ferson SS. Intrathecal baclofen therapy in children. Neurosurg. Focus 2006 21 : e3.
6. Hoving MA, Evers SMAA, Ament AJHA, van Raak EPM, Vles JSH. Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost-effectiveness analysis. Dev. Med. Child Neurol. 2008 50 : 450 455.
7. de Lissovoy G, Matza LS, Green H, Werner M, Edgar T. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy. J. Child Neurol. 2007 22 : 49 59.
8. Gooch JL, Oberg WE, Grams B, Ward LA, Walker ML. Care provider assessment of intrathecal baclofen in children. Dev. Med. Child Neurol. 2004 46 : 548 552.
9. Kolaski K, Logan LR. A review of the complications of intrathecal baclofen in patients with cerebral palsy. Neurorehabilitation 2007 22 : 383 395.
10. Motta F, Buonaguro V, Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J. Neurosurg. 2007 107 (1 Suppl. 32 5.
11. Vender JR, Hester S, Waller JL, Rekito A, Lee MR. Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J. Neurosurg. 2006 104 (1 Suppl. 9 15.
12. Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL. Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery 2001 49 : 753 756.
13. Albright AL, Barry MJ, Shafron DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev. Med. Child Neurol. 2001 43 : 652 657.
14. Campbell WM, Ferrel A, McLaughlin JF et al. Long-term safety and efficacy of continuous intrathecal baclofen. Dev. Med. Child Neurol. 2002 44 : 660 665.
15. Scheinberg AM, O'Flaherty S, Chaseling R, Dexter M. Continuous intrathecal baclofen infusion for children with cerebral palsy: a pilot study. J. Paediatr. Child Health 2001 37 : 283 288.
16. Law M, Baptiste S, Carswell A, McColl MA, Polatajko H, Pollock N. Canadian Occupational Performance Measure. Toronto : Canadian Association of Occupational Therapist, 1998.
17. Kiresuk TJ, Lund SH. Goal Attainment Scaling. In : Attkisson CC, ed. Evaluation of Human Service Programs. New York : Academic Press, 1978 341 370.
18. King GA, McDougall J, Palisano RJ, Gritzan J, Tucker MA. Goal attainment scaling: its use in evaluating pediatric therapy programs. Phys. Occup. Ther. Pediatr. 1999 19 : 31 52.
19. Ottenbacher KJ, Cusick A. Goal attainment scaling as a method of clinical service evaluation. Am. J. Occup. Ther. 1990 44 : 519 525.
20. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964 192 : 540 542.
21. Barry MJ, Van Swearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev. Med. Child Neurol. 1999 41 : 404 411.
22. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics 1995 7 : 490 502.
23. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev. Med. Child Neurol. 1997 39 : 214 223.
24. Krach LE, Nettleton A, Klempka B. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump. Pediatr. Rehabil. 2006 9 : 210 218.
25. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J. Neurosurg. 2003 98 : 291 295.
26. Woon K, Tsegaye M, Vloeberghs MH. The role of intrathecal baclofen in the management of primary and secondary dystonia in children. Br. J. Neurosurg. 2007 21 : 355 358.
27. Motta F, Stignani C, Antonello CE. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales. J. Pediatr. Orthop. 2008 28 : 213 217.
28. Fitzgerald JJ, Tsegaye M, Vloeberghs MH. Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases. Br. J. Neurosurg. 2004 18 : 240 245.
29. Gilmartin R, Bruce D, Storrs BB et al. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J. Child Neurol. 2000 15 : 71 7.
30. Murphy NA, Irwin MCN, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch. Phys. Med. Rehabil. 2002 83 : 1721 1725.
31. Taha J, Favre J, Janszen M, Galarza M, Taha A. Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed Pumps. Neurosurgery 2004 55 : 390 394.